Publikasi Scopus FKUI Tahun 2010 s/d 2020 (data Per 3 Februari 2021)

Hankey G.J., Wong K.S.L., Chankrachang S., Chen C., Crimmins D., Frayne J., Kim J.S., Li Y., Liou C., Merican J.S., Misbach J., Navarro J., Shinohara Y., Wang Y., Yoon B.-W.
7102816661;34769113300;25031222600;57190860165;16052374000;7003947459;57191682031;55719155700;7101807334;13403518000;6507584784;7402580018;57203303862;8320879700;13310144900;
Management of cholesterol to reduce the burden of stroke in Asia: Consensus statement
2010
International Journal of Stroke
5
3
209
216
13
Stroke Unit, Department of Neurology, Royal Perth Hospital, Perth, Australia; Prince of Wales Hospital and the Chinese University of Hong Kong, Shatin, Hong Kong; Northern Neuroscience Center, Chiang Mai University and Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand; Department of Pharmacology, National University of Singapore, Singapore; Central Coast Neuroscience Research Group, Gosford, NSW, Australia; The Alfred Hospital, Melbourne, Australia; Asan Medical Center and University of Ulsan College of Medicine, Seoul, South Korea; Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Chang-Gung Memorial Hospital at Kaohsiung, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Prince Court Medical Centre, Kuala Lumpur, Malaysia; Department of Neurology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Philippine Heart Center and University of Santo Tomas, Quezon City, Philippines; Federation of National Public Service Personnel Mutual Aid Associations Tachikawa Hospital, Tokyo, Japan; Beijing Tiantan Hospital, Capital Medical University, Beijing, China; Seoul National University Hospital, Seoul, South Korea
Hankey, G.J., Stroke Unit, Department of Neurology, Royal Perth Hospital, Perth, Australia; Wong, K.S.L., Prince of Wales Hospital and the Chinese University of Hong Kong, Shatin, Hong Kong; Chankrachang, S., Northern Neuroscience Center, Chiang Mai University and Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand; Chen, C., Department of Pharmacology, National University of Singapore, Singapore; Crimmins, D., Central Coast Neuroscience Research Group, Gosford, NSW, Australia; Frayne, J., The Alfred Hospital, Melbourne, Australia; Kim, J.S., Asan Medical Center and University of Ulsan College of Medicine, Seoul, South Korea; Li, Y., Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Liou, C., Chang-Gung Memorial Hospital at Kaohsiung, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Merican, J.S., Prince Court Medical Centre, Kuala Lumpur, Malaysia; Misbach, J., Department of Neurology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Navarro, J., Philippine Heart Center and University of Santo Tomas, Quezon City, Philippines; Shinohara, Y., Federation of National Public Service Personnel Mutual Aid Associations Tachikawa Hospital, Tokyo, Japan; Wang, Y., Beijing Tiantan Hospital, Capital Medical University, Beijing, China; Yoon, B.-W., Seoul National University Hospital, Seoul, South Korea
Stroke is a major cause of morbidity and mortality in Asia, and its pattern is changing. The incidence of haemorrhagic stroke is declining while the incidence of ischaemic stroke caused by large artery atherothromboembolism is increasing secondary to an increase in the prevalence of hypercholesterolaemia. The Working Group on Stroke and Lipids Management in Asia Consensus Panel assembled leading experts from the region to reach a consensus on how to address this challenge. The group discussed the observational epidemiology of the relationship between cholesterol and risk of stroke, the clinical trial evidence base for cholesterol-lowering for stroke prevention, and issues specific to stroke and lipid management for Asian doctors and patients. Stroke guidelines from many of the Asian countries have recently recommended consideration of statins for recurrent stroke prevention in patients with previous ischaemic stroke or transient ischaemic attack. However, because these recommendations have yet to be implemented widely, there is a need to educate Asian physicians and patients about the importance of adequate control of hypercholesterolaemia. Further trials of statins in Asian patients are also needed, particularly in those with intracranial stenosis. © 2010 The Authors. Journal compilation © 2010 World Stroke Organization.
Asia; Lipids; Prevention; Risk factors; Statins; Stroke
cholesterol; hydroxymethylglutaryl coenzyme A reductase inhibitor; icosapentaenoic acid; pravastatin; simvastatin; article; Asia; cerebrovascular accident; clinical trial; human; hypercholesterolemia; incidence; middle cerebral artery occlusion; morbidity; mortality; patient education; physician; practice guideline; prevalence; priority journal; recurrent disease; risk factor; stroke; thromboembolism; transient ischemic attack; Asia; Cerebral Hemorrhage; Cholesterol; Consensus; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Stroke
17474930
20536617
Article
Q2